Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 239

1.

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.

Friend S, Richman S, Bloomgren G, Cristiano LM, Wenten M.

BMC Neurol. 2016 Aug 24;16(1):150. doi: 10.1186/s12883-016-0674-4.

2.

Metallosis Presenting as a Progressive Neurologic Deficit Four Years after a Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis: A Case Report.

Richman SH, Razzano AJ, Morscher MA, Riley PM Sr.

Spine (Phila Pa 1976). 2016 May 11. [Epub ahead of print]

PMID:
27172284
3.

A novel in vivo mouse model of implant related spine infection.

Dworsky E, Hegde V, Loftin A, Richman S, Hu Y, Lord E, Francis KP, Miller L, Wang J, Scaduto A, Bernthal NM.

J Orthop Res. 2016 Apr 26. doi: 10.1002/jor.23273. [Epub ahead of print]

PMID:
27116085
4.

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.

Seligmann JF, Elliott F, Richman SD, Jacobs B, Hemmings G, Brown S, Barrett JH, Tejpar S, Quirke P, Seymour MT.

JAMA Oncol. 2016 Feb 11. doi: 10.1001/jamaoncol.2015.6065. [Epub ahead of print]

PMID:
26867820
5.

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.

Richman SD, Southward K, Chambers P, Cross D, Barrett J, Hemmings G, Taylor M, Wood H, Hutchins G, Foster JM, Oumie A, Spink KG, Brown SR, Jones M, Kerr D, Handley K, Gray R, Seymour M, Quirke P.

J Pathol. 2016 Mar;238(4):562-70. doi: 10.1002/path.4679. Epub 2016 Jan 29.

6.

Acute Ovarian Insufficiency and Uterine Infarction Following Uterine Artery Embolization for Postpartum Hemorrhage.

Elsarrag SZ, Forss AR, Richman S, Salih SM.

Clin Med Rev Case Rep. 2015 Jun;2(2). pii: 040.

7.

Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial.

Richman SD, Adams R, Quirke P, Butler R, Hemmings G, Chambers P, Roberts H, James MD, Wozniak S, Bathia R, Pugh C, Maughan T, Jasani B; FOCUS4 Trial Management Group.

J Clin Pathol. 2016 Jan;69(1):35-41. doi: 10.1136/jclinpath-2015-203097. Epub 2015 Sep 7.

8.

Deficient mismatch repair: Read all about it (Review).

Richman S.

Int J Oncol. 2015 Oct;47(4):1189-202. doi: 10.3892/ijo.2015.3119. Epub 2015 Aug 12. Review.

9.

Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Zuber J, Rosen S, Shonts B, Sprangers B, Savage TM, Richman S, Yang S, Lau SP, DeWolf S, Farber D, Vlad G, Zorn E, Wong W, Emond J, Levin B, Martinez M, Kato T, Sykes M.

Am J Transplant. 2015 Oct;15(10):2691-703. doi: 10.1111/ajt.13325. Epub 2015 May 18.

10.

Active pollinator choice by Heliconia 'fits the bill'.

Bronstein JL, Richman SK.

Trends Plant Sci. 2015 Jul;20(7):403-4. doi: 10.1016/j.tplants.2015.04.010. Epub 2015 May 1.

PMID:
25941136
11.

Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.

Smith CG, Fisher D, Harris R, Maughan TS, Phipps AI, Richman S, Seymour M, Tomlinson I, Rosmarin D, Kerr D, Chan AT, Peters U, Newcomb PA, Idziaszczyk S, West H, Meade A, Kaplan R, Cheadle JP.

Clin Cancer Res. 2015 Aug 1;21(15):3453-61. doi: 10.1158/1078-0432.CCR-14-3136. Epub 2015 Apr 14.

12.

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.

Dong-Si T, Gheuens S, Gangadharan A, Wenten M, Philip J, McIninch J, Datta S, Richert N, Bozic C, Bloomgren G, Richman S, Weber T, Clifford DB.

J Neurovirol. 2015 Dec;21(6):637-44. doi: 10.1007/s13365-015-0316-4. Epub 2015 Mar 14.

13.

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.

Dong-Si T, Richman S, Wattjes MP, Wenten M, Gheuens S, Philip J, Datta S, McIninch J, Bozic C, Bloomgren G, Richert N.

Ann Clin Transl Neurol. 2014 Oct;1(10):755-64. doi: 10.1002/acn3.114. Epub 2014 Oct 9.

14.

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B.

Ann Neurol. 2014 Dec;76(6):802-12. doi: 10.1002/ana.24286. Epub 2014 Oct 24.

15.

Effect of religiosity and dysfunctional dating attitudes on youth substance use.

Tharp AT, DeWall CN, Richman SB, Noonan RK.

J Addict. 2014;2014:143709. doi: 10.1155/2014/143709. Epub 2014 Aug 5.

16.

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.

Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, Cheadle JP, Fisher D, Kaplan R, Quirke P, Seymour MT, Richman SD, Meijer GA, Ylstra B, Heideman DA, de Haan AF, Punt CJ, Koopman M.

Clin Cancer Res. 2014 Oct 15;20(20):5322-30. doi: 10.1158/1078-0432.CCR-14-0332. Epub 2014 Aug 19.

17.

Ecological implications of reduced forage quality on growth and survival of sympatric geese.

Richman SE, Leafloor JO, Karasov WH, McWilliams SR.

J Anim Ecol. 2015 Jan;84(1):284-98. doi: 10.1111/1365-2656.12270. Epub 2014 Aug 27.

PMID:
25081822
18.

Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.

Bozic C, Subramanyam M, Richman S, Plavina T, Zhang A, Ticho B.

Eur J Neurol. 2014 Feb;21(2):299-304. doi: 10.1111/ene.12304. Epub 2013 Nov 30.

PMID:
24894998
19.

Response.

Smith CG, West H, Harris R, Idziaszczyk S, Maughan TS, Kaplan R, Richman S, Quirke P, Seymour M, Moskvina V, Steinke V, Propping P, Hes FJ, Wijnen J, Cheadle JP.

J Natl Cancer Inst. 2014 Apr 26;106(5). pii: dju087. doi: 10.1093/jnci/dju087. No abstract available.

20.

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

Maughan TS, Meade AM, Adams RA, Richman SD, Butler R, Fisher D, Wilson RH, Jasani B, Taylor GR, Williams GT, Sampson JR, Seymour MT, Nichols LL, Kenny SL, Nelson A, Sampson CM, Hodgkinson E, Bridgewater JA, Furniss DL, Roy R, Pope MJ, Pope JK, Parmar M, Quirke P, Kaplan R.

Br J Cancer. 2014 Apr 29;110(9):2178-86. doi: 10.1038/bjc.2014.182. Epub 2014 Apr 17.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk